ReviewMolecules (Basel, Switzerland)2025
Doping of Magnéli Phase-New Direction in Pollutant Degradation and Electrochemistry.
Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This review summarizes the recent developments in titanium suboxide (TSO) doping and the application of doped materials in pollutant degradation and electrochemistry. Doping is mainly limited to transition and rare-earth metals, with some exceptions, of similar ionic radii and charge, that can replace Ti ions in TSO without too much disturbance to the lattice. Consequently, doping is limited to below 10 at%, which predominantly induces oxygen vacancy formation. Doping mechanisms are weighted, and their effect on conductivity, stability, and catalytic activity is overviewed. High-temperature H
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.